Clinical Trials
10 trialsNCT07590648 2026-05-15
E-STOP2
Hospital Universitari Vall d'Hebron Research Institute
Phase 4 Not yet recruiting
NCT04983901 2026-04-06
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Phase 2 Completed
NCT04948463 2026-03-20
ELSA-FN
Murdoch Childrens Research Institute
Phase 4 Completed
NCT01431326 2023-09-06
PTN_POPS
Duke University
Completed
NCT03485950 2022-03-15
Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
M.D. Anderson Cancer Center
Phase 2 Completed
NCT04187755 2019-12-06
Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever
Indonesia University
Phase 4 Completed
NCT01484015 2018-07-18
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
Wake Forest University Health Sciences
Phase 1 Completed
NCT02732327 2017-07-21
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Forest Laboratories
Phase 2 Terminated
NCT00020865 2013-12-19
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00529282 2012-08-01
A Study of Ceftobiprole in Patients With Fever and Neutropenia.
Basilea Pharmaceutica
Phase 3 Terminated